Add BrightSurf on Google Email

The Lancet


New combination drug treatment for hepatitis C

A new combination drug treatment has shown to be more effective in treating chronic hepatitis C than the current standard. The treatment, peginterferon alfa-2b plus ribavirin, achieved higher sustained viral response rates compared to interferon alfa-2b plus ribavirin, especially in patients with genotype 1 infection.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 20, 2001

New approach to management of ulcerative colitis

A randomised controlled trial found that patient-centred self-management training reduced relapse times and hospital visits, while maintaining health-related quality-of-life scores. This alternative approach to traditional outpatient care may improve health-service provision and reduce costs for chronic diseases.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 20, 2001

Health in a 24-hour society

A review article in The Lancet highlights the negative effects of shift work on health and productivity. Desynchronisation of circadian rhythms can lead to poor sleep, gastrointestinal disorders, and cardiovascular disease, emphasizing the need for employers to create effective working environments.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 20, 2001

Girls make twin brothers heavier (p 560)

A Belgian study of non-identical twins found that female twins prolong gestation by 0.4 weeks, resulting in a higher birthweight for their male co-twin. Birthweights of unlike-sex twins were also compared, with female twins having similar weights to same-sex twins but male twins weighing an average of 78g more.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 16, 2001

West meets East - WHO tuberculosis treatment

A recent trial found that WHO short-course chemotherapy was as effective as traditional Russian treatments in curing patients with tuberculosis. However, the results highlight the challenges of implementing changes in a healthcare system with entrenched cultural and structural barriers.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 9, 2001

Childhood abuse strongly linked to revictimisation

A UK study found that childhood maltreatment and revictimisation of children and women are common problems. Abusive experiences co-occurred in both childhood and adulthood, with repetition and severity of childhood abuse independently associated with specific types of adult revictimisation.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 9, 2001

New model for early meningitis detection

A new model for detecting early meningitis epidemics in sub-Saharan Africa has been developed, using weekly incidence thresholds to identify outbreaks. The model uses clinic-based weekly incidence of 5-10 cases per 100,000 inhabitants to detect all meningitis epidemics with high sensitivity.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 26, 2001

Benefits outweigh burden of chemotherapy

A statistical analysis of 47 randomized trials involving 18,000 women found that chemotherapy improves survival time adjusted for quality of life for both younger and older women. Younger women treated with chemotherapy gained an average of 10.3 months of relapse-free survival within 10 years.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 26, 2001

Stem-cell research: Drawing the line

The use of embryonic stem cells is a contentious issue, with proponents arguing that they hold promise for medical breakthroughs. However, opponents claim that destroying an embryo is tantamount to infanticide. Scientists generally favor the use of embryonic stem cells due to their versatility.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 23, 2001

Early case of resistance to new antibiotic

A new case of resistance to the antibiotic linezolid has been reported in a patient with MRSA infection, highlighting the need for clinical laboratories to perform susceptibility tests. The finding is rare and has occurred after limited use of the drug, emphasizing the importance of monitoring its effectiveness.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 19, 2001

Concern over safety of yellow fever vaccine

Two fatal cases of haemorrhagic fever associated with yellow fever 17DD substrain vaccine were reported in Brazil, highlighting the need to review the vaccine's safety. The cases led Philippe Marianneau and colleagues from Institut Pasteur to emphasize the importance of investigating mechanisms of attenuation of yellow-fever virus.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 12, 2001